Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
VERFAHREN MIT FIXER INTERMITTIERENDER DOSIERUNG VON CEDIRANIB
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2017753704
EP Publication Number
3417294
E-Number
1451696
Language
EN
PCT Number
US17017804
Publication Date
26.12.2018 A
01.12.2021 B1
Registration Date
01.12.2021
AT Publication Date
15.12.2021
Application Date
14.02.2017
Registration Number
-
Priorities
15.02.2016
US
201662295421 P
IPC
C07K 16/28 20060101AFI20210125BHEP
Maximum Duration of Protection
14.02.2037
Owner
Astrazeneca AB151 85 SödertäljeSE
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH6701 Rockledge Drive, Suite 700, MSC 7788 Bethesda, MD 20892US